Lasa Supergenerics - Quaterly Results

28 May 2025 Evaluate
The Turnover for the quarter ended March 2025 of Rs. 391.38 millions increase by 71.54% from Rs. 228.16 millions.The Net Loss for the quarter ended March 2025 is Rs. -142.92 millions as compared to Net Loss of Rs. -153.00 millions of corresponding quarter ended March 2024 Operating profit Margin for the quarter ended March 2025 improved to 58.03% as compared to -39.73% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 391.38 228.16 71.54 1424.48 1043.35 36.53 1424.48 1043.35 36.53
Other Income 23.92 0.09 26477.78 50.12 1.02 4813.73 50.12 1.02 4813.73
PBIDT 58.03 -39.73 -246.06 112.77 22.64 398.10 112.77 22.64 398.10
Interest 1.08 5.60 -80.71 26.92 19.32 39.34 26.92 19.32 39.34
PBDT -182.19 -133.06 36.92 -70.84 -84.41 -16.08 -70.84 -84.41 -16.08
Depreciation 38.99 26.61 46.52 123.00 106.73 15.24 123.00 106.73 15.24
PBT -221.18 -159.67 38.52 -193.84 -191.14 1.41 -193.84 -191.14 1.41
TAX -78.26 -6.67 1073.31 -46.26 26.18 -276.70 -46.26 26.18 -276.70
Deferred Tax -78.26 -6.67 1073.31 -46.26 26.18 -276.70 -46.26 26.18 -276.70
PAT -142.92 -153.00 -6.59 -147.58 -217.32 -32.09 -147.58 -217.32 -32.09
Equity 501.01 501.01 0.00 501.01 501.01 0.00 501.01 501.01 0.00
PBIDTM(%) 14.83 -17.41 -185.15 7.92 2.17 264.84 7.92 2.17 264.84

Lasa Supergenerics Share Price

9.90 -0.10 (-1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×